Daratumumab Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma

被引：0
|
作者：
Ma, Panelyi [1 ]
Xiao, Xiubin [1 ]
Yuan, Shunzong [1 ]
Chen, Xilin [1 ]
Zhao, Shihua [1 ]
Cheng, Nana [1 ]
Lu, Yun [1 ]
Chen, Junli [1 ]
Wang, Yueqi [1 ]
Huang, Wenrong [1 ]
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 5, Lymphoma & Plasma Cell Dis Dept Hematol, Beijing, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-184811
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea
    Lee, Ho Sup
    Min, Chang-Ki
    Lee, Je-Jung
    Kim, Kihyun
    Kim, Seok Jin
    Yoon, Dok Hyun
    Eom, Hyeon-Seok
    Lee, Hyewon
    Lee, Won Sik
    Shin, Ho-Jin
    Lee, Ji Hyun
    Park, Yong
    Jo, Jae-Cheol
    Do, Young Rok
    Mun, Yeung-Chul
    Lee, Mark Hong
    ANNALS OF HEMATOLOGY, 2016, 95 (06) : 911 - 919
  • [22] The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea
    Ho Sup Lee
    Chang-Ki Min
    Je-Jung Lee
    Kihyun Kim
    Seok Jin Kim
    Dok Hyun Yoon
    Hyeon-Seok Eom
    Hyewon Lee
    Won Sik Lee
    Ho-Jin Shin
    Ji Hyun Lee
    Yong Park
    Jae-Cheol Jo
    Young Rok Do
    Yeung-Chul Mun
    Mark Hong Lee
    Annals of Hematology, 2016, 95 : 911 - 919
  • [23] Prolonged Survival With a Longer Duration of Maintenance Lenalidomide After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
    Mian, Idrees
    Milton, Denai R.
    Shah, Nina
    Nieto, Yago
    Popat, Uday R.
    Kebriaei, Partow
    Parmar, Simrit
    Oran, Betul
    Shah, Jatin J.
    Manasanch, Elisabet E.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    Bashir, Qaiser
    CANCER, 2016, 122 (24) : 3831 - 3837
  • [24] Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study
    Badros, Ashraf
    Foster, Laahn
    Anderson Jr, Larry D.
    Chaulagain, Chakra P.
    Pettijohn, Erin
    Cowan, Andrew J.
    Costello, Caitlin
    Larson, Sarah
    Sborov, Douglas W.
    Shain, Kenneth H.
    Silbermann, Rebecca
    Shah, Nina
    Chung, Alfred
    Krevvata, Maria
    Pei, Huiling
    Patel, Sharmila
    Khare, Vipin
    Cortoos, Annelore
    Carson, Robin
    Lin, Thomas S.
    Voorhees, Peter
    BLOOD, 2025, 145 (03) : 300 - 310
  • [25] Panobinostat As a Maintenance Therapy after Autologous Hematopoietic Cell Transplantation for Patients with Multiple Myeloma
    Nishihori, Taiga
    Baz, Rachid
    Ochoa, Leonel
    Puglianini, Omar Alexis Castaneda
    Shain, Kenneth H.
    Brayer, Jason B.
    Locke, Frederick L.
    Kim, Jongphil
    Song, Jinming
    Dumala, Michael
    Alsina, Melissa
    BLOOD, 2019, 134
  • [26] FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma
    Pulte, Elizabeth Dianne
    Dmytrijuk, Andrew
    Nie, Lei
    Goldberg, Kirsten B.
    McKee, Amy E.
    Farrell, Ann T.
    Pazdur, Richard
    ONCOLOGIST, 2018, 23 (06): : 734 - 739
  • [27] Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma
    Poenisch, Wolfram
    Ploetze, Madlen
    Holzvogt, Bruno
    Andrea, Marc
    Schliwa, Thomas
    Zehrfeld, Thomas
    Hammerschmidt, Doreen
    Schwarz, Maik
    Edelmann, Thomas
    Becker, Cornelia
    Hoffmann, Franz Albert
    Schwarzer, Andreas
    Kreibich, Ute
    Gutsche, Kerstin
    Reifenrath, Kolja
    Schwarzbach, Heidrun
    Heyn, Simone
    Franke, Georg-Nikolaus
    Jentzsch, Madlen
    Leiblein, Sabine
    Schwind, Sebastian
    Lange, Thoralf
    Vucinic, Vladan
    Alali, Haifa-Katrin
    Niederwieser, Dietger
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (11) : 2013 - 2022
  • [28] EARLY AUTOLOGOUS STEM CELL TRANSPLANTATION IMPROVES SURVIVAL IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Cavallo, F.
    Spencer, A.
    Gay, F.
    Hajek, R.
    Petrucci, M. T.
    Ben Yehuda, D.
    Carella, A. M.
    Vallone, L. M.
    Oliva, S.
    Petro, D.
    Crippa, C.
    Siniscalchi, A.
    Gilestro, M.
    Pour, L.
    Maracci, L.
    Pescosta, N.
    Liberati, M.
    Magarotto, V.
    Scudla, V.
    Benevolo, G.
    Pulini, S.
    Caravita, T.
    Hardan, I.
    Boccadoro, M.
    Palumbo, A.
    HAEMATOLOGICA, 2014, 99 : 520 - 520
  • [29] Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma
    Sauer, Sandra
    Kriegsmann, Katharina
    Nientiedt, Cathleen
    Schmitt, Anita
    Mueller-Tidow, Carsten
    Raab, Marc-Steffen
    Kauer, Joseph
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2023, 50 (05) : 371 - 380
  • [30] The importance of autologous stem cell transplantation in improving outcomes in newly diagnosed patients with multiple myeloma
    Gertz, Morie A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (11) : 2060 - 2062
12345